SM
PCSA icon

Sabby Management’s Processa Pharmaceuticals PCSA Stock Holding History

Sabby Management’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,944
Closed -$115K – 53
2024
Q1 		$115K Buy
+1,944
New +$154K 0.07% 31

Other funds holding PCSA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
MSG
Main Street Group Glen Allen, Virginia $429M AUM 34.03% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $162M AUM 22.52% 1-Year Est. Return

Sabby Management's PCSA Position: Q2 2024 in Review

Sabby Management sold out of Processa Pharmaceuticals (PCSA) in Q2 2024, closing a stake of 1,944 shares — an estimated $115K sold.

Sabby Management first reported a position in PCSA in Q1 2024 and held it in 1 quarter. The position peaked at $115K in Q1 2024. 7 funds tracked by Wall St. Rank hold PCSA as of Q2 2024.

  • Sabby Management reported no remaining Processa Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Sabby Management sold 1,944 Processa Pharmaceuticals shares in Q2 2024, an estimated $115K.
  • Sabby Management first reported a position in Processa Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Sabby Management's Processa Pharmaceuticals position peaked at $115K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q2 2024.

Based on Sabby Management's 13F filing for Q2 2024, filed 14 Aug 2024.